Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up

by D. S. Kasatkin, S. S. Molchanova, N. N. Spirin
Published 2019-11-01

Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis

by A. N. Boyko, S. A. Sivertseva, N. N. Spirin
Published 2020-08-01

The phenomenon of focal peripheral nerve constriction: review of the literature

by D. S. Druzhinin, E. S. Naumova, S. S. Nikitin, N. N. Spirin
Published 2019-04-01

Analysis of probable predictors of aggressive multiple sclerosis

by N. N. Spirin, E. V. Kiseleva, N. N. Spirina
Published 2020-01-01

Endothelial dysfunction in multiple sclerosis and management options using alpha-lipoic acid

by N. N. Spirina, N. N. Spirin, A. N. Boyko
Published 2015-12-01

Study of tactile sensitivity by Semmes–Weinstein monofilaments in patients with carpal tunnel syndrome and healthy individuals

by I. G. Mikhailyuk, N. N. Spirin, E. V. Salnikov
Published 2015-02-01

Efficacy of kinesiotaping in patients with the initial signs of carpal tunnel syndrome

by I. G. Mikhaylyuk, N. N. Spirin, E. V. Sal’nikov
Published 2019-04-01

Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis

by A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova
Published 2019-12-01

Features vertebroneurological status in patients with nodular transformation of thyroid mation

by N. N. Spirin, Yu. K. Alexandrov, Ye. L. Kasatkin, T. Yu. Nikanorova, A. N. Sencha
Published 2011-04-01

Aspects of clinical differential diagnosis of radiculopathy in Lyme disease and spondylosis

by N. S. Baranova, L. A. Nizovtseva, N. N. Spirin, Ye. G. Shipova, V. A. Bulanova, N. Yu. Krotova
Published 2010-08-01

DIFFERENTIAL DIAGNOSIS OF RADICULOPATHY IN LYME BORRELIOSISAND DYSTROPHIC LESIONS OF THE VERTEBRAL COLUMN

by L A Nizovtseva, Nataliya Sergeyevna Baranova, N N Spirin, E G Shipova, V A Bulanova, N Yu Krotova
Published 2010-06-01

COVID-19 vaccination guidelines for patients with multiple sclerosis

by N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Published 2021-04-01

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

by A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Published 2019-11-01

Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

by K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Published 2020-06-01

Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

by N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Published 2020-10-01